Office of the Director, National Institutes of Health; Amended Notice of Meeting, 20900 [2019-09734]
Download as PDF
<![CDATA[
20900
Federal Register / Vol. 84, No. 92 / Monday, May 13, 2019 / Notices
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Complementary and Integrative Health
Special Emphasis Panel; Promoting Research
on Music and Health.
Date: June 19, 2019.
Time: 8:00 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center, Salon H, 5701 Marinelli
Road, Rockville, MD 20852.
Contact Person: Pamela Eugenia Jeter,
Ph.D., Scientific Review Officer, Office of
Scientific Review, Division of Extramural
Activities, NCCIH, NIH, 6707 Democracy
Boulevard, Suite 401, Bethesda, MD 20892—
547, 301–435–2591, pamela.jeter@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.213, Research and Training
in Complementary and Alternative Medicine,
National Institutes of Health, HHS)
Dated: May 7, 2019.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–09739 Filed 5–10–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Director, National
Institutes of Health; Amended Notice
of Meeting
jbell on DSK3GLQ082PROD with NOTICES
Notice is hereby given of a change in
the meeting of the Council of Councils,
May 17, 2019, 08:15 a.m. to May 17,
2019, 04:00 p.m., National Institutes of
Health, The Cloisters Building, 1
Cloisters Court, Bethesda, MD 20892
which was published in the Federal
Register on February 08, 2019, 84 FR
2889.
The meeting notice is amended to
change the open and closed session
meeting times as follows: The morning
open session end time will change from
12:00 p.m. to 11:30 a.m.; the closed
session will change from 12:00 p.m.–
1:30 p.m. to 11:45 a.m.–12:15 p.m.; and
the afternoon open session start time
will change from 1:30 p.m. to 1:15 p.m.
Dated: May 7, 2019.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–09734 Filed 5–10–19; 8:45 am]
BILLING CODE 4140–01–P
VerDate Sep<11>2014
16:29 May 10, 2019
Jkt 247001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel; NCI R38
Review.
Date: June 21, 2019.
Time: 10:30 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: NCI Shady Grove, 9609 Medical
Center Drive, Room 7W110, Rockville, MD
20850 (Telephone Conference Call).
Contact Person: Sanita Bharti, Ph.D.
Scientific Review Officer, Research Programs
Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH
9609 Medical Center Drive, Room 7W122
Bethesda, MD 20892–9750 240–276–5909
sanita.bharti@nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel Validation
of Cancer Markers (UH2/UH3).
Date: June 26, 2019.
Time: 12:00 p.m. to 1:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: NCI Shady Grove, 9609 Medical
Center Drive, Room 7W244, Rockville, MD
20850 (Telephone Conference Call).
Contact Person: John P. Cairns, Ph.D.
Scientific Review Officer, Research Programs
Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH
9609 Medical Center Drive, Room 7W244
Bethesda, MD 20892–9750 240–276–5415
paul.cairns@nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; SEP–7: NCI
Clinical and Translational R21 and Omnibus
R03.
Date: June 28, 2019.
Time: 11:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: NCI Shady Grove, 9609 Medical
Center Drive, Room 7W640, Rockville, MD
20850 (Telephone Conference Call).
Contact Person: Saejeong J. Kim, Ph.D.
Scientific Review Officer, Special Review
Branch, Division of Extramural Activities,
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
National Cancer Institute, NIH 9609 Medical
Center Drive, Room 7W640 Bethesda, MD
20892–9750 240–276–5179 saejeong.kim@
nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; UE4/U24
Review.
Date: July 9, 2019.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: NCI Shady Grove, 9609 Medical
Center Drive, Room 7W110, Rockville, MD
20850 (Telephone Conference Call).
Contact Person: Robert E. Bird, Ph.D.
Scientific Review Officer, Research Program
Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH
9609 Medical Center Drive, Room 7W110
Bethesda, MD 20892–9750 240–276–6344
birdr@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Advancing
Cancer Immunotherapy by MitigatingImmune related adverse events.
Date: July 17, 2019.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Washington/Rockville, 1750
Rockville Pike Rockville, MD 20852.
Contact Person: Shari W. Campbell, DPM,
MSHS Scientific Review Officer, Resources
and Training Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH 9609 Medical Center Drive,
Room 7W612 Bethesda, MD 20892–9750
240–276–7381 shari.campbell@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: May 7, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–09736 Filed 5–10–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
E:\FR\FM\13MYN1.SGM
13MYN1
]]>Agencies
[Federal Register Volume 84, Number 92 (Monday, May 13, 2019)]
[Notices]
[Page 20900]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-09734]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Director, National Institutes of Health; Amended
Notice of Meeting
Notice is hereby given of a change in the meeting of the Council of
Councils, May 17, 2019, 08:15 a.m. to May 17, 2019, 04:00 p.m.,
National Institutes of Health, The Cloisters Building, 1 Cloisters
Court, Bethesda, MD 20892 which was published in the Federal Register
on February 08, 2019, 84 FR 2889.
The meeting notice is amended to change the open and closed session
meeting times as follows: The morning open session end time will change
from 12:00 p.m. to 11:30 a.m.; the closed session will change from
12:00 p.m.-1:30 p.m. to 11:45 a.m.-12:15 p.m.; and the afternoon open
session start time will change from 1:30 p.m. to 1:15 p.m.
Dated: May 7, 2019.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-09734 Filed 5-10-19; 8:45 am]
BILLING CODE 4140-01-P
